Clinical Decision and Support System Market is Growing Exponentially in Order to Gain More Demand by 2026

Clinical
Decision Support System (CDSS) is healthcare IT solution that
provides evidence-based information to provide optimum care to
patient. Clinical decision support system assist healthcare
providers, by analyzing of patient data and using that information to
aid in diagnosis of specific disease and treatment plan for same.
Information input offered by CDSS to clinicians and primary care
providers helps to improve the quality of the care by reducing drug
overdose, drug interaction, adverse events, and assisting in
diagnosis.
Market Dynamics
Major driver for
growth of the clinical decision support system market is various
benefits offered by the CDSS in both inpatient settings, ambulatory
settings, and clinics. Medical error is one of the significant
contributor to cause of death worldwide. According to data published
by Centre for Disease Control and Prevention (CDC), 2013, more than
150,000 deaths are reported annually in the U.S. due to medical error
(ADR, wrong diagnosis, prescription error)
According to World
Health Organization (WHO) report, in 2017, medication error costs US$
42 billion annually worldwide. An estimated 43 million patient safety
incidence occur annually and around 1 in 10 patient get harmed due to
medication error while receiving healthcare. These incidence of
medication error could be addressed with use of CDSS. Increasing
prevalence of chronic disease is another driver for wide adoption of
CDSS. According to WHO Factsheet, around 73% of global deaths are
expected to be from chronic disease by 2020.
Various benefits
provided by the CDSS to drive growth of the clinical decision support
system market
According to report
by Healthcare Information and Management Systems Society in 2011,
Clinical decision support system has been proved to be helpful in
reducing number of days at hospitals, reduction in hospital
readmissions, preventing the incidence of medical error, and adverse
events due to clinical decision. Advantages offered by clinical
decision support system are expected to increase its adoption among
end users, which in turn is driving growth for the clinical decision
support system market.
Request For
Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/2054
Increasing
chronic disease prevalence worldwide to propel growth of the clinical
decision support system market
Increasing
prevalence of the chronic disease such as cancer, diabetes, and
cardiovascular disease worldwide is propelling demand for its
accurate diagnosis, treatment plan, and continuous care. According to
the data published by American Heart Association, in 2016, annual
cost of cardiovascular disease and stroke in 2011 – 2012 was US$
193.1 billion in medical care and about US$ 123 billion in lost
productivity from premature death. This cost can be reduced by
adopting clinical decision support system, which could prevent and
control major risk factors for CVD such as hypertension,
hypercholesterolemia, and diabetes.
Key players
operating in the clinical decision support system market include
Cerner Corporation, Allscripts Healthcare Solutions, Inc., IBM Watson
Health, GE Healthcare, Change Healthcare, Zynx Health, Carestream
Health Inc., First Databank, Inc., NextGen Healthcare Information
Systems, Agfa Healthcare, Medical Information Technology Inc., Athena
Health, Wolters Kluwer NU, Siemens Healthineers, and Philips
Healthcare.
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Comments
Post a Comment